Company: SGBAF
Filing Date: 2025-01-17
Form Type: DRS/A
Source: 0000950123-25-000378
Chunk: 15

Company: SES S.A.
Filing Date: 2025-01-17
Form: DRS/A
Chunk 15
---
 promptly following the Closing. The Closing Cash Consideration

7

Confidential Treatment Requested by SES

Pursuant to 17 C.F.R. Section 200.83

distributable to Intelsat’s shareholders will be reduced by amounts payable in respect of Intelsat’s outstanding warrants, which will expire, terminate and become void at the Closing
and represent only the right to receive the “Black-Scholes” value of the outstanding Intelsat warrants, which value will be determined by a third-party valuation firm in accordance with the applicable warrant agreements and paid to the
holders of Intelsat warrants in cash. All or a portion of the remaining Closing Cash Consideration will be held back for the duration of the Liquidation to satisfy any remaining liabilities of Intelsat and to cover the costs of winding up the
affairs of Intelsat. Once the Liquidation has been completed, any remaining Closing Cash Consideration held by Intelsat will be distributed to Intelsat’s shareholders.

Q: Who can help answer my questions?

A: If you are an Intelsat shareholder and would like a copy of this prospectus, or if you have questions about the Acquisition or the
other matters discussed in this prospectus, you should contact:

Intelsat S.A.

7900 Tysons One Place

McLean, VA
22102

Attn: Investor Relations

Tel: (703) 559-6800

Q: Where can I find more information about SES and Intelsat?

A:You can find more information about SES and Intelsat from the various sources described under “Where You Can Find More Information” beginning on page 165 of this prospectus.

8

Confidential Treatment Requested by SES

Pursuant to 17 C.F.R. Section 200.83

SUMMARY

This summary highlights selected information from this prospectus. It may not contain all the information that is important to you. Accordingly, we urge you to read this prospectus carefully and in its entirety, including the Annexes hereto, the documents incorporated herein by reference, the registration statement to which this prospectus relates, and all other documents attached to or incorporated into this prospectus to fully understand the Share Purchase Agreement, the Acquisition and the Transactions. The page references have been included in this summary to direct you to a more complete description of the topics presented below. See also the section titled “Where You Can Find More Information” beginning on page 165.

The Parties to the